Ignite Creation Date:
2024-07-17 @ 10:46 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06488560
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-05-07
Brief Title:
The Impact of Commercial Blenderized Formula on Caloric Needs Gastrointestinal Symptoms and Gut Microbiome in Children With Cerebral Palsy CP
Sponsor:
The University of Texas Health Science Center Houston
Organization:
The University of Texas Health Science Center Houston
Study Overview
Official Title:
The Impact of Commercial Blenderized Formula on Caloric Needs Gastrointestinal Symptoms and Gut Microbiome in Children With Cerebral Palsy A Single Center Randomized Open Label Clinical Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the Pediatric Quality of Life Inventory Gastrointestinal Symptoms Scale Gastrointestinal Symptoms Scale GI-PedsQL differences to assess the differences in stool microbiome and stool metabolomics to assess differences in salivary cytokine profile to assess differences in weight change to compare the use of antacid medications and to compare the use of laxative medications in patients on commercial formulas CF versus commercial blenderized tube feed CBTF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None